Interventional Cardiology News and Research

RSS

Ben Taub Hospital building national reputation for cardiovascular services

For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.

25 Jul 2015

Boston Scientific commences new study to evaluate fully resorbable drug-eluting scaffold system

Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study (FAST) is a prospective, single arm study designed to assess the safety and performance of this next generation scaffold for the treatment of atherosclerotic coronary lesions.

21 Jul 2015

No significant research undertaken to prevent or treat PPCM in healthy pregnant women, study reveals

Peripartum cardiomyopathy (PPCM) is a rare disorder characterized by weakened pumping of the heart, or "left ventricular dysfunction," which results in otherwise healthy pregnant women experiencing heart failure shortly before or up to five months after they deliver healthy babies. Despite the seriousness of this condition, a new study published in the Canadian Journal of Cardiology revealed that no significant research has been undertaken to explore how to prevent or treat this disorder.

16 Jul 2015

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

17 Jun 2015

Essential Medical to highlight MANTA Large Bore closure system at 2015 Jefferies Global Healthcare Conference

Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.

3 Jun 2015

Sheffield scientists to showcase novel medical discoveries during International Clinical Trials Day

WORLD-leading researchers and scientists from Sheffield Teaching Hospitals Foundation Trust and the University of Sheffield will be giving people in Sheffield and beyond a unique insight into how they can contribute to groundbreaking medical discoveries during International Clinical Trials Day (Wednesday 20 May 2015).

15 May 2015

Cedars-Sinai Heart Institute sets new national standard for most adult heart transplants

The Cedars-Sinai Heart Institute completed 120 adult heart transplants and two adult heart-lung transplants in 2014, setting a new national standard for the most adult heart transplants performed in a single year.

9 Apr 2015

Anticoagulant drug bivalirudin shows mixed results in MATRIX trial

Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints--a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding--as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

23 Mar 2015

Using arm as access point for catheter-based heart procedures lowers risk of major bleeding, death

Patients with acute coronary syndrome undergoing coronary angiogram, a procedure used to assess blockages in the heart's arteries, had a significantly lower risk of major bleeding and death if their interventional cardiologist accessed the heart through an artery in the arm rather than the groin, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

23 Mar 2015

Novel device improves in-hospital safety outcomes, cognitive scores at discharge

An investigational device that deflects debris away from the brain during transcatheter aortic valve replacement seems to improve in-hospital safety outcomes and cognitive scores at discharge, according to preliminary findings from a small randomized study presented at the American College of Cardiology's 64th Annual Scientific Session.

18 Mar 2015

Study compares effectiveness of CT scan and traditional stress test in patients with chest pain

Patients with chest pain have similar rates of heart attacks and other major cardiac events within two years whether they were evaluated with a new type of CT scan or the traditional stress test, according to results presented today by Duke Medicine researchers at a meeting of the American College of Cardiology.

17 Mar 2015

Team Alvimedica unveils World Heart Health Charity Tour to raise funds, awareness for heart health

While the young sailors on board Team Alvimedica are racing around the world in the Volvo Ocean Race, they are leaving in their wake significant donations to a children's heart health charity at each of the 10 stopover ports of this challenging global competition.

12 Feb 2015

$Study assessing efficacy of Neovasc Reducer for treatment of Refractory Angina published in NEJM$

Study assessing efficacy of Neovasc Reducer for treatment of Refractory Angina published in NEJM

Neovasc Inc. today announced that the final results from its COSIRA study assessing the efficacy and safety of the Neovasc Reducer for treatment of Refractory Angina, were published today in the New England Journal of Medicine.

5 Feb 2015

Loyola University Medical Center opens center to provide treatments for diseased heart valves

Loyola University Medical Center has opened a multidisciplinary Valve Center that offers patients a full range of treatments for diseased heart valves.

10 Dec 2014

Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.

12 Nov 2014

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond.

30 Oct 2014

Minimally invasive valve-repair procedures offer hope for patients who have heart-valve problems

Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral valve insufficiency. The later turned her life into a battle for breath, eliminating almost all activities and even making sleep a struggle. She couldn't sleep for more than 20-minutes at a time without waking in a fit of coughing. Thanks to a leading-edge procedure performed at UT Southwestern Medical Center, Mrs. Henderson is now breathing - and sleeping - easy.

9 Oct 2014

Obesity, other cardiovascular issues to be the focus of Brazilian Congress of Cardiology

More than 4,000 extra wide seats were made to accommodate Brazil's increasing obese population during the World Cup this year. Obesity affects nearly 20 percent of the population in Brazil and is currently classified as a disability. This and other cardiovascular issues, such as the overuse of technology, will be the focus of the Brazilian Congress of Cardiology, a joint event with the European Society of Cardiology and the Brazilian Society of Cardiology, 26-29 September.

23 Sep 2014

Osprey Medical to release enhanced AVERT Plus System at TCT Meeting

Osprey Medical Inc. has developed a new smart syringe and LCD display system, soon to be incorporated with its existing AVERT System.

16 Sep 2014

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.

2 Sep 2014